Jump Trading’s Haemonetics HAE Stock Holding History

Jump Trading’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,232	Closed	-$222K	–	268
2020 Q1	$222K	Buy	+2,232	New	+$242K	0.17%	140

Other funds holding HAE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Trading's HAE Position: Q2 2020 in Review

Jump Trading sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 2,232 shares — an estimated $222K sold.

Jump Trading first reported a position in HAE in Q1 2020 and held it in 1 quarter. The position peaked at $222K in Q1 2020. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

Jump Trading reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
Jump Trading sold 2,232 Haemonetics shares in Q2 2020, an estimated $222K.
Jump Trading first reported a position in Haemonetics in Q1 2020 and held it in 1 quarter.
Jump Trading's Haemonetics position peaked at $222K in Q1 2020.
285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.